CAMOSUNATE NOT BANNED – NAFDAC

Read Time:1 Minute, 8 Second

By ‘Leke Yusuf

The National Agency for Food Drugs Administration and Control (NAFDAC) has refuted claims circulating on social media that Camosunate, an antimalarial medicine containing artesunate and amodiaquine, has been banned in Nigeria. The Agency clarifies that it has never banned Camosunate or medicines containing this combination.

In a press statement on Saturday, the Agency urged members of the public to “disregard the false claim and report suspected adverse drug reactions through the Med Safety App or at the nearest NAFDAC office.

“The Agency clarifies that it has never banned Camosunate or medicines containing the artesunate-amodiaquine combination.

“Some of the symptoms reported in the viral claim may be associated with known side effects of Camosunate, including nausea, vomiting, diarrhoea, abdominal pain, headache, dizziness, drowsiness and loss of appetite. However, suspected adverse drug reactions should be reported to NAFDAC for proper assessment.”

The statement signed by Prof. Mojisola Adeyeye, the Director-General of NAFDAC asked “members of the public and healthcare professionals are encouraged to report suspected adverse drug reactions through the NAFDAC Med Safety App, available for download on Android and iOS devices, or at the nearest NAFDAC office.

“NAFDAC urges the public to stop circulating the false claim. Those who have already shared it are encouraged to disseminate this clarification through the same channels to help counter misinformation and prevent unnecessary public concern.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %